Harish Srinivas

Harish Srinivas

Registered Patent Agent

Pittsburgh, PA
Phone: 412.454.5006    Fax: 412.281.0717


Harish Srinivas is a registered patent agent in the Intellectual Property Department of Pepper Hamilton LLP, resident in the Pittsburgh office. Dr. Srinivas currently concentrates his work on patent preparation and prosecution of both U.S. and international applications, due diligence and freedom to operate analysis.

Dr. Srinivas’s research expertise covers a broad range of life science areas such as biochemistry, organic chemistry, pharmaceuticals, biotechnology and molecular biology. He holds a Ph.D. in biochemistry from the Indian Institute of Science, India, where his research was focused on transcriptional activation of mammalian RNA polymerase II. He did his post-doctoral fellowship at MD Anderson Cancer Center in Houston, Texas where he worked on the role of retinoic acid receptors in lung cancer.

Before joining Pepper, Dr. Srinivas was a member of the faculty at the University of Pittsburgh where he led a team to identify and target novel signaling pathways for lung cancer treatment. His scientific experience involves wide range of disease models such as cancer and diabetes. During his tenure at University of Pittsburgh, he was a recipient of the Innovative Cancer Research Award from the University of Pittsburgh Cancer Institute. He also served as an ad hoc reviewer for many peer reviewed journals.

Dr. Srinivas has published in a number of peer reviewed journals and his research has been presented at numerous national meetings. Some of his publications and speaking engagements include:

  • “Ligand-Independent Anti-Apoptotic Function of Estrogen Receptor Beta in Lung Cancer Cells” (corresponding author), Mol Endocrinology 24(9): 1737-47, 2010
  • "Estrogen Receptor Beta Functions Through Non-Genomic Mechanisms in Lung Cancer Cells” (corresponding author), Mol Endocrinology 23(2):146-156, 2009
  • “Non-Genomic Function of Estrogen Receptors in Lung Cancer,” FASEB Summer Research Conference, Carefree Resort, AZ, July 27- August 1, 2008
  • “Mitogen-Activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression Through an NF-kB-Dependent Pathway,” J Biol Chem 282(6): 3507-3519, 2007
  • “Akt Phosphorylates and Suppresses the Transactivation of Retinoic Acid Receptor Alpha,” Biochem J 395(3): 653-662, 2006
  • “cJun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor-Alpha,” Mol Cell Biol 25(3):1054-1069, 2005


  • Ph.D., Biochemistry, Indian Institute of Science, Bangalore, India, 2000
  • M.Sc., Biochemistry, Bangalore University, 1993
  • B.Sc., Chemistry, Botany and Zoology, Bangalore University, 1991

Bar Admissions

  • U.S. Patent and Trademark Office

Practice Areas

Data protection laws have changed, so we have revised our Privacy Policy.